Home  Top Stories  Sports  Entertainment  Health News  Business  Personal Finance 
Real Estate  Business Finance  Insurance  Consulting 
Tax News  Forum


 

Writers






 


Featured Articles







BUSINESS



 


 

 
Search:

 

 



Drug Herceptin appears to Cure HER-2 Breast Cancer According to Journal

October 20th 2005

Drug Herceptin appears to Cure HER-2 Breast Cancer According to Journal

Cancer Cell

There appears to be a cure for women with HER II positive breast cancer, which accounts for 20 to 25 percent of breast cancer cases.  Women treated with Heceptin had a 46% reduction in reoccurring breast cancer. It is proving to be highly effective against an aggressive form of breast cancer that tends to strike younger women.

The New England Journal of Medicine reported that the drug Herceptin, which was licensed only for advanced breast cancer, has effectively targeted a specific protein that halted the spread of the disease.    

This my usher in a new era in cancer research where drugs are tailored made to target specific receptors identified for specific diseases.  The old method of research was based on trial and error where researchers screen thousand of compounds to find one that works.  Also, this particular drug targets only diseased cells. 

 
 

It is rare that the New England Journal of Medicine (NEJM) uses such definitive language in describing a potential cure.  The results are, it concludes, “revolutionary, not evolutionary”. “Our care of patients with HER II positive breast cancer must change today.”

The generic name for Herceptin is traastuzumab.  The drug is not a chemotherapy drug.  It is a hormone or special type of protein that attacks a protein in a tumor cell.  Herceptin is made by Genetech.  The common therapy is to excise the tumors and implement a combination chemotherapy and Herceptin treatment. 

There were three Herceptin research studies that involved 6500 women with early-stage breast cancer.  One study was funded by Hercetpin’s European marketer, Roche, and the others were sponsored by the National Cancer Institute.  Herceptin was approved in 1998 for advanced breast cancer.

Abstract 1 Abstract 2

Comments on this Article

Submit your own Article

  RSS Feeds to our health content

Add to My Yahoo!

 

By Dan Wilson
Best Syndication Staff Writer

Books on Breast Cancer

Keywords and misspellings:  Her-2 her 2 canser sells herseptin


Google
 
Web BestSyndication.com

About   Contact   site map

Copyright 2005 Best Syndication                                            Last Updated Saturday, July 10, 2010 09:40 PM